Atropos Health
Total Raised
$50.33MInvestors Count
19Deal Terms
1Funding, Valuation & Revenue
7 Fundings
Atropos Health has raised $50.33M over 7 rounds.
Atropos Health's latest funding round was a Series B for $33M on May 23, 2024.
Atropos Health's latest post-money valuation is from May 2024.
Sign up for a free demo to see Atropos Health's valuations in May 2024 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
5/23/2024 | Series B | $33M | 4 | |||
8/10/2023 | Series A - II | |||||
8/4/2022 | Series A | |||||
12/10/2020 | Seed | |||||
12/10/2020 | Incubator/Accelerator |
Date | 5/23/2024 | 8/10/2023 | 8/4/2022 | 12/10/2020 | 12/10/2020 |
|---|---|---|---|---|---|
Round | Series B | Series A - II | Series A | Seed | Incubator/Accelerator |
Amount | $33M | ||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 4 |
Atropos Health Deal Terms
1 Deal Term
Atropos Health's deal structure is available for 1 funding round, including their Series B from May 23, 2024.
Round | Series B |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B |
Atropos Health Investors
19 Investors
Atropos Health has 19 investors. Breyer Capital invested in Atropos Health's Series B funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
8/4/2022 | 5/23/2024 | 3 Series A, Series A - II (2023), Series B (2024) | Venture Capital | Texas | ||
8/10/2023 | 5/23/2024 | 2 Series A - II, Series B (2024) | Corporate Venture | California | ||
8/4/2022 | 5/23/2024 | 2 Series A, Series B (2024) | Family Office | California | ||
Venture Capital | Illinois | |||||
Corporate Venture | New Jersey |
First funding | 8/4/2022 | 8/10/2023 | 8/4/2022 | ||
|---|---|---|---|---|---|
Last Funding | 5/23/2024 | 5/23/2024 | 5/23/2024 | ||
Investor | |||||
Rounds | 3 Series A, Series A - II (2023), Series B (2024) | 2 Series A - II, Series B (2024) | 2 Series A, Series B (2024) | ||
Board Seats | |||||
Type | Venture Capital | Corporate Venture | Family Office | Venture Capital | Corporate Venture |
Location | Texas | California | California | Illinois | New Jersey |
Compare Atropos Health to Competitors
Datavant operates as a data platform company for healthcare, focusing on data connectivity and interoperability within the healthcare sector. The company offers services that include health data exchange, record retrieval, data transformation, and revenue cycle management, aimed at facilitating secure and efficient data movement and connection. Datavant primarily serves health plans, healthcare providers, life sciences companies, and legal and insurance sectors, providing them with tools related to data. It was founded in 2017 and is based in Phoenix, Arizona.
Dandelion operates as a healthcare technology company that uses a precision medicine platform and clinical artificial intelligence (AI) marketplace. The company provides services that integrate patient data with AI tools to support clinical research, development, and commercialization. Dandelion serves the life sciences sector, offering solutions for early clinical research, clinical development, post-approval product differentiation, and indication expansion. It was founded in 2020 and is based in Syosset, New York.
Culmination Bio focuses on the development of novel clinical insights, diagnostics, and therapeutics in the healthcare sector. It offers the development of therapeutic targets, diagnostic opportunities, and care process models. It was founded in 2022 and is based in Saint George, Utah.
Komodo Health focuses on providing data-driven insights in the healthcare sector. The company offers a software platform that analyzes a variety of data to provide insights for various healthcare stakeholders. These insights aim to assist life sciences, patient advocacy, healthcare practitioners, and payers in their efforts to support patient care and manage costs. It was founded in 2014 and is based in New York, New York.
Evidation is involved in measuring health in everyday life within the digital health sector. The company provides a platform for individuals to track health activities, participate in research, and manage their data privacy. Evidation serves the life sciences, government, and non-profit organizations. It was founded in 2012 and is based in San Mateo, California.
Inovalon operates in the healthcare industry, offering data-driven, cloud-based solutions. The company provides a platform that integrates national-scale connectivity, primary source data access, and analytics to support clinical outcomes and health economics. Inovalon's services cater to various sectors, including payers, providers, pharmacies, and life sciences organizations, providing tools for revenue cycle management, care quality management, and workforce management. Inovalon was formerly known as MedAssurant. It was founded in 1998 and is based in Bowie, Maryland.
Loading...